Dana Monet Fitzgerald, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 Central Park Dr Ste 201, Steamboat Springs, CO 80487 Phone: 970-871-1900 Fax: 970-870-3138 |
Sheila Marie Fountain, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 Central Park Drive, Suite #201, Steamboat Springs, CO 80487 Phone: 970-871-1900 Fax: 970-870-3138 |
Steven Alan Ross, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 405 Anglers Drive, Suite A, Steamboat Springs, CO 80488 Phone: 970-879-2327 Fax: 970-879-1972 |
Ronald F Famiglietti, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 Central Park Drive, Suite 201, Steamboat Springs, CO 80487 Phone: 970-871-1900 Fax: 970-870-3138 |
News Archive
Long term use of incense increases the risk of developing cancers of the respiratory tract, according to a new study. The new analysis, which the authors say is the first prospective investigation of incense and cancer risk, appears in the October 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Eliminating bacteria's DNA and boosting antimicrobial proteins that already exist may help prevent middle ear infections from reoccurring. These are the findings from a Nationwide Children's Hospital study that examined how an immune defense protein common in the middle ear interacts with a structure meant to protect a colony of bacteria.
In a major public health success, the introduction of pneumococcal conjugate vaccine PCV13, or Prevnar 13, in 2010 in the United States is associated with reduction in socioeconomic disparities and the near elimination of Black-white-based racial disparities for invasive pneumococcal disease.
"Kenya on Monday became the first African country to introduce a routine vaccine against pneumococcal disease, which claims the lives of more than half a million children under five each year," Deutsche Presse Agentur/The Hindu reports. The GAVI Alliance, which is supporting the vaccine's roll out, "is aiming to introduce the vaccine to 19 developing countries - including Nicaragua, Guyana, Yemen and Sierra Leone - within a year and hopes to reach more than 40 nations by 2015, depending on funding."
› Verified 7 days ago